For the Biome has secured financing from Vermont-based JHCapital


For the Biome has entered into a partnership with the JHCapital family office of Jim Crook and Allison Maino.

For the Biome

Photo ©

For the Biome (Dummerson, VT) has entered into a partnership with the JHCapital family office of Jim Crook and Allison Maino. Crook has over 35 years of experience, and a strong track record of growing companies in Vermont and beyond. He is the former CEO of IDX Systems Corporation and plays lead governance roles in Aspenti Health, DealerPolicy, RCxRules, MediRevv, and Greensea Systems, among others. Maino, Crook’s daughter and partner has spent her career in advertising and sponsorship sales before joining the family office.

"Really smart people with a really good idea and the proven experience of scaling a business makes investment decisions easy," said Crook. "Barbi, Paul and Kelli are those people. In addition, and very importantly, our respective approaches to building companies by always putting the customer first and treating our team members with dignity and respect, are principles that both JHCapital and For The Biome share."

"Jim and Allison's support and strategic expertise will enable our mission to grow quickly and flourish,” said Kelli Rooney Hanzalik, president of For the Biome, in a press release.

For the Biome’s new line, called Sentient Skincare, will be introduced early in 2020. It includes Empower Powder 2-in-1 Cleanser/Mask, Invigorate Powder Mask, Soothe Powder Cleanser, Restore Essence Spray, Adapt Essence Spray, Shield Face Serum, and Awaken Eye Serum.

"I've formulated our products to deliver a sensually exceptional experience by maximizing communication between our skin, now recognized as the 'third brain,' and the microbiome,” explained For the Biome’s co-founder and master herbalist Paul Schulick. “We're using our time-tested formulation philosophy to create the next chapter in healthy skin care and unite inner and outer beauty."

Related Videos
woman working on laptop computer by window
© 2024 MJH Life Sciences

All rights reserved.